Kontro, M., Stein, A. S., Rimpiläinen, J., Pyörälä, M., Siitonen, T., Ball, B., Myllymäki, M., Zeidner, J., Searle, D. E., Witherall, R., Bono, P., Nimba, A., Williamson, J., Aakko, S., Hollmén, M., Zeidan, A., Daver, N. (2025). Transfusion independence, hematological improvement and associated safety outcomes with bexmarilimab and azacitidine in HR-MDS: Results of the bexmab Phase 1/2 study. Blood. https://doi.org/10.1182/blood-2025-5627